BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6344632)

  • 1. Lymphosarcoma cell leukemia and other non-Hodgkin's lymphomas in leukemic phase.
    Mintzer DM; Hauptman SP
    Am J Med; 1983 Jul; 75(1):110-20. PubMed ID: 6344632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell lymphosarcoma cell leukemia: dynamics of surface-membrance immunoglobulin. Value for differentiation from chronic lymphocytic leukemia.
    Cohen HJ
    Ann Intern Med; 1978 Mar; 88(3):317-22. PubMed ID: 343679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosette-formation with mouse red blood cells in chronic lymphocytic leukemia and leukemic non-Hodgkin's lymphomas.
    Wirthmüller R; Gerhartz H
    Klin Wochenschr; 1980 Jul; 58(14):743-5. PubMed ID: 7453087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
    Hicks MJ; Grogan TM; Fielder K; Spier CM
    Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, pathologic and immunologic features of patients with non-Hodgkin's lymphoma in a leukemic phase. A retrospective analysis of 34 patients.
    Fram RJ; Skarin AT; Rosenthal DS; Pinkus G; Nadler LM
    Cancer; 1983 Oct; 52(7):1220-8. PubMed ID: 6349787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.
    Diamond LW; Nathwani BN; Rappaport H
    Cancer; 1982 Sep; 50(6):1122-35. PubMed ID: 7104953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic problems in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia.
    Borowitz M; Bigner SH; Johnston WW
    Acta Cytol; 1981; 25(6):665-74. PubMed ID: 6947670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concanavalin A-induced agglutination of human leukemic and lymphoma cells.
    Maca RD
    Cancer Res; 1976 Apr; 36(4):1218-21. PubMed ID: 1063062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations.
    Come SE; Jaffe ES; Andersen JC; Mann RB; Johnson BL; DeVita VT; Young RC
    Am J Med; 1980 Nov; 69(5):667-74. PubMed ID: 7001897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
    Said JW; Pinkus GS
    Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.
    Kinoshita K; Kamihira S; Ikeda S; Yamada Y; Muta T; Kitamura T; Ichimaru M; Matsuo T
    Cancer; 1982 Oct; 50(8):1554-62. PubMed ID: 6981451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic (or stage V) lymphosarcoma.
    Mathé G; Misset JL; Gil-Delgado M; Delgado M; De Vassal F
    Recent Results Cancer Res; 1978; 65():88-107. PubMed ID: 581797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
    Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
    Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on receptor for mouse erythrocytes in lymphocytes of patients with malignant lymphoma.
    Krawczyk-Kuliś M; Hołowiecki J; Stella-Hołowiecka B; Rudzka E; Jarczok K
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):511-6. PubMed ID: 583207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.